| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC3909 |
| Trial ID | NCT06464861 |
| Disease | Primary Mediastinal B-Cell Lymphoma | Mantle Cell Lymphoma | Diffuse Large B Cell Lymphoma |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell|CAR-NK cell |
| Treatment | CD19 CAR-NK/T cells |
| Phase | Phase1 |
| Recruitment status | Not Recruiting |
| Title | Sequential Treatment With 7x19 CAR-T After Umbilical Cord Blood Derived CD19 CARNK in Relapsed/Refractory B Cell Lymphoma |
| Year | 2024 |
| Country | China |
| Company sponsor | Second Affiliated Hospital, School of Medicine, Zhejiang University |
| Other ID(s) | 2024 (0673) |
| Cohort 1 | |||||||||
|
|||||||||